# Succinylcholine-induced rhabdomyolysis in a patient with RYR1 and BCHE variants: A case report

**Authors:** Tracy E Harrison, Toby N Weingarten, Juraj Sprung

PMC · DOI: 10.17305/bb.2025.13435 · Biomolecules and Biomedicine · 2025-11-10

## TL;DR

A patient with genetic variants in RYR1 and BCHE developed rhabdomyolysis after succinylcholine, highlighting a possible interaction between these genes.

## Contribution

First reported case linking concurrent RYR1 and BCHE variants to rhabdomyolysis following general anesthesia.

## Key findings

- Patient experienced rhabdomyolysis after succinylcholine with RYR1 and BCHE variants.
- RYR1 c.1840C>T and BCHE c.293A>G variants likely synergistically caused increased Ca2+ release.
- Findings suggest a novel clinical-genetic interaction in anesthesia-related complications.

## Abstract

Masseter muscle spasm after succinylcholine can herald malignant hyperthermia (MH) in genetically susceptible individuals. We aimed to describe the perioperative course and genetic findings in a patient who developed transient masseter spasm and postoperative rhabdomyolysis after general anesthesia. This single-patient case report draws on perioperative observations, laboratory testing, and whole-genome sequencing. Immediately after induction with propofol and succinylcholine, the patient experienced transient masseter spasm; anesthesia was then maintained with total intravenous anesthesia (propofol and remifentanil). Postoperatively, laboratory studies showed severe rhabdomyolysis with mild pigment nephropathy; the patient received intravenous hydration, laboratory values normalized by postoperative day 4, and discharge occurred in good condition. Whole-genome sequencing identified heterozygous ryanodine receptor 1 (RYR1) c.1840C>T (p.Arg614Cys)—a known MH-susceptibility variant in the skeletal-muscle ryanodine receptor—and butyrylcholinesterase (BCHE) c.293A>G (p.Asp98Gly), which reduces butyrylcholinesterase activity and delays succinylcholine hydrolysis. The coexistence of these variants likely synergistically increased sarcoplasmic reticulum Ca2+ release and prolonged succinylcholine effect, precipitating rhabdomyolysis; to our knowledge, this appears to be the first reported case linking concurrent RYR1 and BCHE variants to rhabdomyolysis following general anesthesia.

## Linked entities

- **Genes:** RYR1 (ryanodine receptor 1) [NCBI Gene 6261], BCHE (butyrylcholinesterase) [NCBI Gene 590]
- **Chemicals:** succinylcholine (PubChem CID 5314), propofol (PubChem CID 4943), remifentanil (PubChem CID 60815)
- **Diseases:** rhabdomyolysis (MONDO:0005290), malignant hyperthermia (MONDO:0018493)

## Full-text entities

- **Genes:** BCHE (butyrylcholinesterase) [NCBI Gene 590] {aka BCHED, CHE1, CHE2, E1}, RYR1 (ryanodine receptor 1) [NCBI Gene 6261] {aka CCO, CMYO1A, CMYO1B, CMYP1A, CMYP1B, KDS}
- **Diseases:** rhabdomyolysis (MESH:D012206), MH (MESH:D008305), Masseter muscle spasm (MESH:D014313), nephropathy (MESH:D007674)
- **Chemicals:** remifentanil (MESH:D000077208), Ca2+ (-), propofol (MESH:D015742), Succinylcholine (MESH:D013390)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Mutations:** c.1840C>T, p.Asp98Gly

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12834312/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12834312/full.md

## References

28 references — full list in the complete paper: https://tomesphere.com/paper/PMC12834312/full.md

---
Source: https://tomesphere.com/paper/PMC12834312